 |
|
| Blog results | Results 1 - 10 of about 35,861 for macular degeneration drug. (0.21 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Age Related Macular Degeneration - http://www.medrounds.org/amd/ | |
| 21 Aug 2008 Duke is a site for this long-anticipated, multicenter clinical trial, which will compare the effectiveness of Lucentis and Avastin in treating this blinding eye disease. dukehealth.org: Health Features - http://www.dukehealth.org/?from=RSS/ |
| 15 Dec 2009 ... this week that it has landed the world's biggest pharmaceutical firm as a partner, exclusively licensing its proprietary human gene target RTP-801 to Pfizer for certain indications including age-related macular degeneration. ... Macular Degeneration News - http://macular.lastmed.com/ [ More results from Macular Degeneration News ] |
| 15 Dec 2009 by Expert Opinion on Drug Safety Expert Opinion on Drug Safety , Early Online, Vol. 0, No. 0, Pages 1-17. MyJournals.org - RSS feed for news from... - http://www.myjournals.org/ |
| 27 Nov 2009 by nystagmite QLT to pay $20-million to settle suit – reportonbusiness.com: globeinvestor.com – dispute centres around royalties on Visudyne, a macular degeneration drug treatment. RetinaEyeDoctor.com | A Retina Eye Blog – a site mainly about macular ... The Blind Buzz - http://nystagmite.wordpress.com/ - References [ More results from The Blind Buzz ] |
| 16 Dec 2009 by admin Physician-researchers at USC received a nearly $16 million grant from the California Institute for Regenerative Medicine to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of ... NDU Blog - http://www.ndu.com/blog/ |
| 1 Dec 2009 by DaveCEO Lucentis-is a drug therapy based on the cancer drug Avastin for wet macular degeneration. The treatment involves periodic injection of the drug directly into the eye. A higher percentage of those treated with Lucentis have shown ... Repo Specialists - http://www.repospecialist.org/ |
| 7 Dec 2009 Currently 47 U.S. eye institutions are involved in macular degeneration research comparing Lucentis and Avastin. The purposes of the study are to determine which drug and treatment schedule is better in treating wet macular degeneration ... AMD Updates - http://www.webrn-maculardegeneration.com/macular-degeneration-blog.html [ More results from AMD Updates ] |
| 16 Dec 2009 by AP FDA panel votes down new use for OSI cancer drug. ... stanleyyork Diagnosis and Treatment of Epithelial Ovarian Cancer | Good Ezines; markhoroszowski Diagnosis and Treatment of Epithelial Ovarian Cancer http://newsdx.com/articles/38769/; mlstotts Migraine Headaches Accurate Diagnosis and Treatment with Neuromuscular Dentistry; danielmietchen [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 1] ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 2 Dec 2009 Previous intravitreal drug delivery (e.g., intravitreal corticosteroid injection, anti-angiogenic drugs besides ranibizumab, or device implantation) in the study eye within the last 12 months. CNV Lesion Exclusion Characteristics ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 2 Dec 2009 QLT continues to study the effectiveness of Visudyne in patients with wet age-related macular degeneration by exploring its use in combination with the class of therapeutics known as anti-VEGF drugs. The punctal plug drug delivery ... Government Wide NEWS - http://www.news.gov.bc.ca/ - References |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
